News: Clostridium dificile diarrhea linked to maternal deaths and stillbirths

Article

In pregnant women, severe Clostridium difficile-associated disease may be an emerging threat.

In pregnant women, severe Clostridium difficile-associated disease may be an emerging threat, according to a report published in the June issue of the American Journal of Obstetrics and Gynecology.

Nadine G. Rouphael, MD, of the Centers for Disease Control and Prevention in Atlanta, and colleagues collected clinical and pathology data on severe cases and surveyed 798 infectious disease consultants in the Emerging Infections Network, of whom 419 (52%) responded.

The researchers collected information on 10 severe cases, including three maternal deaths and three stillbirths. In two cases, the epidemic C difficile strain was identified. In their survey, 37 infectious disease consultants cited a total of 55 cases and 21 complications, most of which occurred during the postpartum period.

Rouphael NG, O'Donnell JA, Bhatnagar J, et al. Clostridium difficile-associated diarrhea: an emerging threat to pregnant women. Am J Obstet Gynecol. 2008:198:635.e1-635.e6.

Related Videos
Understanding combined oral contraceptives and breast cancer risk | Image Credit: health.ucdavis.edu
Why doxycycline PEP lacks clinical data for STI prevention in women
The importance of nipocalimab’s FTD against FNAIT | Image Credit:  linkedin.com
Enhancing cervical cancer management with dual stain | Image Credit: linkedin.com
Fertility treatment challenges for Muslim women during fasting holidays | Image Credit: rmanetwork.com
Understanding the impact of STIs on young adults | Image Credit: providers.ucsd.edu.
CDC estimates of maternal mortality found overestimated | Image Credit: rwjms.rutgers.edu.
Study unveils maternal mortality tracking trends | Image Credit: obhg.com
How Harmonia Healthcare is revolutionizing hyperemesis gravidarum care | Image Credit: hyperemesis.org
Unveiling gender disparities in medicine | Image Credit:  findcare.ahn.org.
Related Content
© 2024 MJH Life Sciences

All rights reserved.